Unlocking the Potential of F2RL3 as a Drug Target and Biomarker

Target Name: F2RL3

NCBI ID: G9002

F2RL3

Unlocking the Potential of F2RL3 as a Drug Target and Biomarker

F2RL3, also known as protease-activated receptor-4 (PARP) 4, is a protein that plays a crucial role in cell signaling and inflammation.PARP 4 is a member of the PARP family, which includes proteins that regulate DNA damage responses, cell signaling, and inflammation.F2RL3 is expressed in various tissues and cells, including neurons, immune cells, and tissues.

The discovery of PARP 4 and its functions has great potential in the development of new drugs and biomarkers.PARP 4 has been identified as a drug target due to its involvement in various cellular processes that are crucial for tumor growth and progression.F2RL3 has also been shown to be a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Understanding the Structure and Function of F2RL3

The PARP family consists of four proteins:PARP1, PARP2, PARP3, and F2RL3.F2RL3 is a 21 kDa protein that is expressed in various tissues, including brain, spinal cord, and peripheral tissues.F2RL3 has a unique structure that consists of a N-terminal transmembrane domain, a catalytic domain, and a C-terminal cytoplasmic domain.

The N-terminal transmembrane domain is the region that gives F2RL3 its unique structure and function.This domain is responsible for the protein's ability to interact with various cellular signaling pathways, including the DNA damage response pathway.The catalytic domain is the region that provides F2RL3 with its catalytic activity.This domain is responsible for the protein's ability to regulate DNA damage responses and cell signaling.

The C-terminal cytoplasmic domain is the region that gives F2RL3 its stability and cytoplasmic localization.This domain is responsible for the protein's ability to interact with various cellular signaling pathways and for its stability in the cytoplasm.

F2RL3's Role in Cell Signaling and Disease

F2RL3 plays a crucial role in cell signaling and disease.As a member of the PARP family, F2RL3 is involved in the regulation of DNA damage responses, cell signaling, and inflammation.

F2RL3's involvement in the DNA damage response pathway is one of its most significant functions.This pathway is responsible for the regulation of DNA repair and replication in response to various forms of damage, including double-strand breaks, single-strand breaks, and insertions or deletions.

F2RL3's involvement in the DNA damage response pathway is crucial for the regulation of cell growth and differentiation.Studies have shown that F2RL3 plays a negative role in the development of cancer, including breast cancer.F2RL3's ability to regulate DNA damage responses may also be a potential drug target for cancer treatment.

F2RL3's involvement in cell signaling is also significant.This includes the regulation of cell proliferation, apoptosis, and migration.Studies have shown that F2RL3 plays a positive role in the regulation of cell proliferation and survival, and that its levels are decreased in various types of cancer.

F2RL3's involvement in inflammation is also significant.This includes the regulation of immune cell function and the regulation of inflammation.Studies have shown that F2RL3 plays a positive role in the regulation of immune cell function and that its levels are increased in various types of inflammation.

F2RL3 as a Biomarker

F2RL3 has also been shown to be a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

F2RL3 has been shown to be involved in the development

Protein Name: F2R Like Thrombin Or Trypsin Receptor 3

Functions: Receptor for activated thrombin or trypsin coupled to G proteins that stimulate phosphoinositide hydrolysis (PubMed:10079109). May play a role in platelets activation (PubMed:10079109)

The "F2RL3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about F2RL3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets